The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, M. A.
Right arrow Articles by Larsen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, M. A.
Right arrow Articles by Larsen, C. P.
The Journal of Immunology, 2002, 169: 5387-5391.
Copyright © 2002 by The American Association of Immunologists


Cutting Edge

Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen1

Matthew A. Williams2,*, Thandi M. Onami2,{dagger}, Andrew B. Adams*, Megan M. Durham*, Thomas C. Pearson*, Rafi Ahmed{dagger} and Christian P. Larsen3,*

* Emory Transplant Center and Department of Surgery, and {dagger} Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322

A continuing concern with CD28 and/or CD40 blockade-based strategies to induce tolerance and mixed chimerism is their potential to disrupt protective immunity to preexisting infections. In this report, we find that preexisting persistent infection with lymphocytic choriomeningitis virus (LCMV) clone 13 prevents the induction of tolerance, mixed chimerism, and donor-reactive T cell deletion. Mice continue to be refractory to tolerance induction even after viremia has been resolved and virus is present only at very low levels in peripheral tissues. Conversely, we find that the full tolerance regimen, or costimulation blockade alone, specifically inhibits already ongoing antiviral immune responses, leading to an inability to control viremia. These findings suggest that ongoing T cell responses continue to depend on costimulatory interactions in the setting of a chronic infection and provide insight into potential risks following costimulation blockade posed by chronic or latent viral infections such as hepatitis C, EBV, and CMV.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Zheng, C. Matte-Martone, D. Jain, J. McNiff, and W. D. Shlomchik
Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia
J. Immunol., May 15, 2009; 182(10): 5938 - 5948.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Whitmire, M. S. Asano, S. M. Kaech, S. Sarkar, L. G. Hannum, M. J. Shlomchik, and R. Ahmed
Requirement of B Cells for Generating CD4+ T Cell Memory
J. Immunol., February 15, 2009; 182(4): 1868 - 1876.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Wang, L. Chen, E. Ahmed, L. Ma, D. Yin, P. Zhou, J. Shen, H. Xu, C.-R. Wang, M.-L. Alegre, et al.
Prevention of Allograft Tolerance by Bacterial Infection with Listeria monocytogenes
J. Immunol., May 1, 2008; 180(9): 5991 - 5999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Stapler, E. D. Lee, S. A. Selvaraj, A. G. Evans, L. S. Kean, S. H. Speck, C. P. Larsen, and S. Gangappa
Expansion of Effector Memory TCR V{beta}4+CD8+ T Cells Is Associated with Latent Infection-Mediated Resistance to Transplantation Tolerance
J. Immunol., March 1, 2008; 180(5): 3190 - 3200.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. A. Fishman
Infection in Solid-Organ Transplant Recipients
N. Engl. J. Med., December 20, 2007; 357(25): 2601 - 2614.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. K. Selin and M. A. Brehm
Frontiers in Nephrology: Heterologous Immunity, T Cell Cross-Reactivity, and Alloreactivity
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2268 - 2277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Koehn, S. Gangappa, J. D. Miller, R. Ahmed, and C. P. Larsen
Patients, pathogens, and protective immunity: the relevance of virus-induced alloreactivity in transplantation.
J. Immunol., March 1, 2006; 176(5): 2691 - 2696.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Kemball, E. D. H. Lee, E. Szomolanyi-Tsuda, T. C. Pearson, C. P. Larsen, and A. E. Lukacher
Costimulation Requirements for Antiviral CD8+ T Cells Differ for Acute and Persistent Phases of Polyoma Virus Infection
J. Immunol., February 1, 2006; 176(3): 1814 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. Wilkes, T. M. Egan, and H. Y. Reynolds
Lung Transplantation: Opportunities for Research and Clinical Advancement
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
S. P Hickman and L. A Turka
Homeostatic T cell proliferation as a barrier to T cell tolerance
Phil Trans R Soc B, September 29, 2005; 360(1461): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. N. Kotton and J. A. Fishman
Viral Infection in the Renal Transplant Recipient
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1758 - 1774.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bushell, E. Jones, A. Gallimore, and K. Wood
The Generation of CD25+CD4+ Regulatory T Cells That Prevent Allograft Rejection Does Not Compromise Immunity to a Viral Pathogen
J. Immunol., March 15, 2005; 174(6): 3290 - 3297.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry and R. Ahmed
Memory CD8 T-Cell Differentiation during Viral Infection
J. Virol., June 1, 2004; 78(11): 5535 - 5545.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.